Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-018923
Filing Date
2023-05-08
Accepted
2023-05-08 17:26:06
Documents
67
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q apto-20230331.htm   iXBRL 10-Q 1723297
2 EX-31.1 apto-ex31_1.htm EX-31 19608
3 EX-31.2 apto-ex31_2.htm EX-31 15598
4 EX-32.1 apto-ex32_1.htm EX-32 8041
5 EX-32.2 apto-ex32_2.htm EX-32 8021
6 GRAPHIC img238802083_0.jpg GRAPHIC 5225
  Complete submission text file 0000950170-23-018923.txt   6987421

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT apto-20230331_pre.xml EX-101.PRE 307278
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT apto-20230331_lab.xml EX-101.LAB 286373
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT apto-20230331_cal.xml EX-101.CAL 37126
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT apto-20230331.xsd EX-101.SCH 43450
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT apto-20230331_def.xml EX-101.DEF 244690
61 EXTRACTED XBRL INSTANCE DOCUMENT apto-20230331_htm.xml XML 1444818
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32001 | Film No.: 23899060
SIC: 2836 Biological Products, (No Diagnostic Substances)